![Sandy Mahatme](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sandy Mahatme
Finansdirektör/CFO på
VOR BIOPHARMA INC.
Förmögenhet: 369 592 $ per 2026-05-31
Profil
Sandesh Mahatme is currently Director at Epirium Bio, Inc. since 2020, Non-Executive Director at Idorsia Ltd. since 2020, Director at Idorsia Pharmaceuticals Ltd. since 2020, Independent Director at CRISPR Therapeutics AG since 2024, Member of the New York State Bar Association, and will be Chief Financial & Business Officer at Vor Biopharma, Inc. starting in 2025.
Former roles include Independent Director at Elcelyx Therapeutics, Inc., Independent Director at Spyre Therapeutics, Inc. from 2015 to 2022, Independent Director at Flexion Therapeutics, Inc. from 2014 to 2021, Senior VP-Finance & Corporate Development at Celgene Corp.
from 2006 to 2012, Chief Financial & Business Officer, Executive VP at Sarepta Therapeutics, Inc. from 2017 to 2020, Senior Vice President at Celgene Switzerland SARL, and President, Chief Financial & Operating Officer at National Resilience, Inc. from 2020 to 2024.
Education includes graduate degrees from Cornell Law School and New York University School of Law.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
IDORSIA LTD. 0,03 % | 2024-12-31 | 64 662 ( 0,03 % ) | 369 592 $ | 2026-05-31 |
| 2026-06-05 | 0 ( -.--% ) | - $ | 2026-05-31 |
Aktiva positioner av Sandy Mahatme
| Företag | Position | Start |
|---|---|---|
| IDORSIA LTD | Direktör/Styrelseledamot | 2020-05-13 |
| CRISPR THERAPEUTICS AG | Direktör/Styrelseledamot | 2024-05-30 |
| VOR BIOPHARMA INC. | Finansdirektör/CFO | 2025-07-09 |
New York State Bar Association
 New York State Bar Association Miscellaneous Commercial ServicesCommercial Services Operates as a bar association | Företagsledare/Principal | - |
Epirium Bio, Inc.
 Epirium Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for rare diseases characterized by impairment of the skeletal muscle, cardiac and neuronal systems | Direktör/Styrelseledamot | 2020-10-13 |
Idorsia Pharmaceuticals Ltd.
 Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceuticals | Direktör/Styrelseledamot | 2020-05-13 |
Tidigare kända positioner av Sandy Mahatme
| Företag | Position | Slut |
|---|---|---|
National Resilience, Inc.
 National Resilience, Inc. BiotechnologyHealth Technology Operates as a biomanufacturing company that develops and produces medicines | President | 2024-06-01 |
| SPYRE THERAPEUTICS, INC. | Direktör/Styrelseledamot | 2022-07-08 |
| FLEXION THERAPEUTICS, INC. | Direktör/Styrelseledamot | 2021-06-01 |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ | ░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Sandy Mahatmes utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
62
Första gradens relationer
15
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 15 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Sarepta Therapeutics, Inc.
 Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Flexion Therapeutics, Inc.
 Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of patients with musculoskeletal conditions | Health Technology |
Elcelyx Therapeutics, Inc.
 Elcelyx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics based on gut sensory modulation | Health Technology |
Epirium Bio, Inc.
Epirium Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for rare diseases characterized by impairment of the skeletal muscle, cardiac and neuronal systems | Health Technology |
Spyre Therapeutics, Inc.
 Spyre Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
New York State Bar Association
New York State Bar Association Miscellaneous Commercial ServicesCommercial Services Operates as a bar association | Commercial Services |
Cornell Law School
 Cornell Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York University School of Law
 New York University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CRISPR Therapeutics AG
 CRISPR Therapeutics AG BiotechnologyHealth Technology Develops gene-based medicines | Health Technology |
Celgene Switzerland SARL
 Celgene Switzerland SARL Pharmaceuticals: MajorHealth Technology Operates as a global biopharmaceutical company | Health Technology |
Idorsia Ltd.
 Idorsia Ltd. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of medicines for unmet medical needs | Health Technology |
Vor Biopharma, Inc.
 Vor Biopharma, Inc. BiotechnologyHealth Technology Engages in developing cell therapies | Health Technology |
Idorsia Pharmaceuticals Ltd.
Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceuticals | Health Technology |
National Resilience, Inc.
National Resilience, Inc. BiotechnologyHealth Technology Operates as a biomanufacturing company that develops and produces medicines | Health Technology |
